Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Phlebotomy55 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A00912 | 34932603 | PLoS One | Abdominal pain and cirrhosis at diagnosis of hemochromatosis: Analysis of 219 referred probands with HFE p.C282Y homozygosity and a literature review. | 2021 | Details |
A06245 | 32952877 | World J Hepatol | Racial disparities in nonalcoholic fatty liver disease clinical trial enrollment: A systematic review and meta-analysis. | 2020 | Details |
A08742 | 32003680 | Curr Pharm Des | Dysmetabolic Hyperferritinemia and Dysmetabolic Iron Overload Syndrome (DIOS): Two Related Conditions or Different Entities? | 2020 | Details |
A08753 | 32000639 | Curr Pharm Des | Dysmetabolic Iron Overload in Metabolic Syndrome. | 2020 | Details |
A10455 | 31330553 | Semin Liver Dis | Hyperferritinemia in Nonalcoholic Fatty Liver Disease: Iron Accumulation or Inflammation? | 2019 | Details |
A11729 | 30774269 | World J Gastroenterol | Iron and liver fibrosis: Mechanistic and clinical aspects. | 2019 | Details |
A11765 | 30761559 | Aliment Pharmacol Ther | Review article: iron disturbances in chronic liver diseases other than haemochromatosis - pathogenic, prognostic, and therapeutic implications. | 2019 | Details |
A16051 | 28593739 | Hepatol Res | Systematic review and meta-analysis to determine the impact of iron depletion in dysmetabolic iron overload syndrome and non-alcoholic fatty liver disease. | 2017 | Details |
A16571 | 28299304 | Adv Biomed Res | Effects of Phlebotomy on Liver Enzymes and Histology of Patients with Nonalcoholic Fatty Liver Disease. | 2017 | Details |
A16862 | 28123936 | Mol Metab | Metabolomic profiling identifies potential pathways involved in the interaction of iron homeostasis with glucose metabolism. | 2016 | Details |
A16974 | 28067690 | J Pediatr Hematol Oncol | Iron Overload in the Liver of 2 Children: Nonalcoholic Steatohepatitis and Juvenile Hemochromatosis. | 2017 | Details |
A17129 | 27976635 | Saudi J Gastroenterol | Outcome of phlebotomy for treating nonalcoholic fatty liver disease: A systematic review and meta-analysis. | 2016 | Details |
A17963 | 27447538 | Ann N Y Acad Sci | Deferoxamine ameliorates hepatosteatosis via several mechanisms in ob/ob mice. | 2016 | Details |
A18112 | 27346296 | Eur J Intern Med | How should hyperferritinaemia be investigated and managed? | 2016 | Details |
A19467 | 26550266 | Int J Clin Exp Med | Prediction of liver injury using the BP-ANN model with metabolic parameters in overweight and obese Chinese subjects. | 2015 | Details |
A21133 | 25524401 | Hepatology | The impact of phlebotomy in nonalcoholic fatty liver disease: A prospective, randomized, controlled trial. | 2015 | Details |
A21542 | 25241989 | Chin J Physiol | Relationship between hemoglobin levels and risk for suspected non-alcoholic fatty liver in Taiwanese adults. | 2014 | Details |
A22193 | 24756010 | Ann Hepatol | Inflammation is not the cause of an elevated serum ferritin in non-alcoholic fatty liver disease. | 2015 | Details |
A22326 | 24659891 | World J Gastroenterol | A randomized trial of iron depletion in patients with nonalcoholic fatty liver disease and hyperferritinemia. | 2014 | Details |
A22578 | 24447492 | Lipids Health Dis | Fasting time and lipid parameters: association with hepatic steatosis--data from a random population sample. | 2014 | Details |
A22854 | 24251709 | J Gastroenterol Hepatol | Treatment of non-alcoholic fatty liver disease. | 2013 | Details |
A23720 | 23538201 | J Pharmacol Exp Ther | Ezetimibe increases hepatic iron levels in mice fed a high-fat diet. | 2013 | Details |
A23783 | 23483818 | World J Gastroenterol | From fatty liver to fibrosis: a tale of "second hit". | 2013 | Details |
A23830 | 23441892 | Aliment Pharmacol Ther | Phase II clinical trial of phlebotomy for non-alcoholic fatty liver disease. | 2013 | Details |
A24459 | 22876027 | World J Gastroenterol | Diagnostic and therapeutic implications of the association between ferritin level and severity of nonalcoholic fatty liver disease. | 2012 | Details |
A24587 | 22720278 | Can J Gastroenterol | Current treatment options for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. | 2012 | Details |
A24799 | 22481446 | Ann Hepatol | Treatment of hyperferritinemia. | 2012 | Details |
A25157 | 22126026 | Adv Clin Chem | Iron overload in nonalcoholic steatohepatitis. | 2011 | Details |
A25272 | 22020821 | Hepatol Int | Non-alcoholic fatty liver disease: is iron relevant? | 2011 | Details |
A25553 | 21718726 | J Hepatol | Iron in fatty liver and in the metabolic syndrome: a promising therapeutic target. | 2011 | Details |
A26233 | 20851820 | QJM | Venesection for non-alcoholic fatty liver disease unresponsive to lifestyle counselling--a propensity score-adjusted observational study. | 2010 | Details |
A26968 | 19444865 | Diabetes Metab Res Rev | Glucose abnormalities in non-alcoholic fatty liver disease and chronic hepatitis C virus infection: the role of iron overload. | 2009 | Details |
A27053 | 19261002 | Hepatol Res | Role of hepatic iron in non-alcoholic steatohepatitis. | 2009 | Details |
A27399 | 18469261 | Am J Clin Nutr | Pathways underlying iron accumulation in human nonalcoholic fatty liver disease. | 2008 | Details |
A27425 | 18405489 | Gastroenterol Hepatol | [Treatment of fatty liver disease]. | 2008 | Details |
A27794 | 17416050 | Rev Prat | [Iron overload and chronic liver diseases]. | 2006 | Details |
A27809 | 17391316 | Am J Gastroenterol | Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study. | 2007 | Details |
A28346 | 15561641 | Best Pract Res Clin Gastroenterol | Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): treatment. | 2004 | Details |
A28349 | 15544735 | Gastroenterol Hepatol | [Study of patients referred for elevated ferritin levels and/or transferrin saturation: significance of non-alcoholic fatty liver disease]. | 2004 | Details |
A28498 | 12508671 | Praxis (Bern 1994) | [Rare, but important chronic liver diseases]. | 2002 | Details |
A28536 | 11910345 | Gastroenterology | Effect of iron depletion in carbohydrate-intolerant patients with clinical evidence of nonalcoholic fatty liver disease. | 2002 | Details |
A28546 | 11603045 | Tidsskr Nor Laegeforen | [Non-alcoholic steatohepatitis]. | 2001 | Details |
A36018 | 19195795 | Med Hypotheses | Getting the iron out: phlebotomy for Alzheimer's disease? | 2009 | Details |
A36021 | 19190144 | Cancer Epidemiol Biomarkers Prev | Iron overload is associated with hepatic oxidative damage to DNA in nonalcoholic steatohepatitis. | 2009 | Details |
A36899 | 16971174 | Hepatol Res | Effect of iron reduction by phlebotomy in Japanese patients with nonalcoholic steatohepatitis: A pilot study. | 2006 | Details |
A37208 | 16257259 | Hepatol Res | Elevation of serum thioredoxin levels in patients with nonalcoholic steatohepatitis. | 2005 | Details |
A43592 | 31335359 | Am J Gastroenterol | ACG Clinical Guideline: Hereditary Hemochromatosis. | 2019 | Details |
A43715 | 31052166 | Int J Mol Sci | Iron-Induced Liver Injury: A Critical Reappraisal. | 2019 | Details |
A44737 | 27486346 | J Blood Med | Clinical applications of therapeutic phlebotomy. | 2016 | Details |
A45061 | 26238272 | Hepatology | Reply: To PMID 25524401. | 2015 | Details |
A45062 | 26238083 | Hepatology | Does the death knell toll for phlebotomy in NAFLD? | 2015 | Details |
A45374 | 24926259 | Case Rep Oncol | Occurrence and Recurrence of Hepatocellular Carcinoma Were Not Rare Events during Phlebotomy in Older Hepatitis C Virus-Infected Patients. | 2014 | Details |
A45613 | 23656418 | Aliment Pharmacol Ther | Commentary: phlebotomy in non-alcoholic fatty liver disease. | 2013 | Details |
A46526 | 17959863 | Diabetes Care | Bloodletting ameliorates insulin sensitivity and secretion in parallel to reducing liver iron in carriers of HFE gene mutations. | 2007 | Details |
A47334 | 16344062 | Gastroenterology | Steatosis is a cofactor in liver injury in hemochromatosis. | 2005 | Details |